How To Successfully Treat Myelofibrosis

Medications

Ruxolitinib is a medication approved to treat myelofibrosis. This medication is also referred to as the JAK inhibitor, and it has the ability to not only treat myelofibrosis, but also ease multiple symptoms associated with the disease, such as anemia, enlarged spleen, bone pain, and excessive sweating at night. Ruxolitinib is a form of drug therapy used to block the processes the genetically mutated genes facilitate. Overall, using medication to treat and relieve the symptoms of myelofibrosis can specifically target genetically mutated cells, stopping them from dividing and creating more genetically mutated cells. Additional medications with the ability to effectively relieve an individual’s myelofibrosis symptoms are thalidomide, lenalidomide, and pomalidomide. These can improve blood cell counts, and even relieve symptoms associated with an enlarged spleen.

Keep reading for information on more treatments for myelofibrosis.